NO980016L - Makrolider - Google Patents
MakroliderInfo
- Publication number
- NO980016L NO980016L NO980016A NO980016A NO980016L NO 980016 L NO980016 L NO 980016L NO 980016 A NO980016 A NO 980016A NO 980016 A NO980016 A NO 980016A NO 980016 L NO980016 L NO 980016L
- Authority
- NO
- Norway
- Prior art keywords
- positions
- acid residue
- macrocyclic ring
- macrolides
- iii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- General Engineering & Computer Science (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9513596.8A GB9513596D0 (en) | 1995-07-04 | 1995-07-04 | Organic compounds |
| GBGB9515495.1A GB9515495D0 (en) | 1995-07-28 | 1995-07-28 | Organic compounds |
| PCT/EP1996/002952 WO1997002285A1 (en) | 1995-07-04 | 1996-07-04 | Macrolides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO980016D0 NO980016D0 (no) | 1998-01-02 |
| NO980016L true NO980016L (no) | 1998-03-02 |
Family
ID=26307320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO980016A NO980016L (no) | 1995-07-04 | 1998-01-02 | Makrolider |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0836616A1 (cs) |
| JP (1) | JPH11509092A (cs) |
| KR (1) | KR19990028724A (cs) |
| CN (1) | CN1193979A (cs) |
| AR (1) | AR006514A1 (cs) |
| AU (1) | AU708004B2 (cs) |
| BR (1) | BR9609324A (cs) |
| CA (1) | CA2224715A1 (cs) |
| CO (1) | CO4750713A1 (cs) |
| CZ (1) | CZ424297A3 (cs) |
| HU (1) | HUP9802320A3 (cs) |
| IL (1) | IL122844A0 (cs) |
| NO (1) | NO980016L (cs) |
| PL (1) | PL324346A1 (cs) |
| SK (1) | SK498A3 (cs) |
| TR (1) | TR199800001T1 (cs) |
| WO (1) | WO1997002285A1 (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6124453A (en) * | 1995-07-04 | 2000-09-26 | Novartis Ag | Macrolides |
| GB9811854D0 (en) * | 1998-06-02 | 1998-07-29 | Ciba Geigy Ag | Organic compounds |
| US7368423B1 (en) * | 2001-12-05 | 2008-05-06 | The Scripps Research Institute | Composition and method for treating chronic allograft rejection |
| EP1768662A2 (en) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
| AR054778A1 (es) | 2005-06-17 | 2007-07-18 | Novartis Ag | Uso de sangliferina en hcv |
| US8067024B2 (en) | 2006-02-10 | 2011-11-29 | Medtronic Vascular, Inc. | Medical devices to prevent or inhibit restenosis |
| CN101289440B (zh) * | 2007-06-29 | 2010-08-25 | 中国热带农业科学院热带生物技术研究所 | 一种多烯大环类化合物及其制备方法与应用 |
| JP5789190B2 (ja) * | 2008-09-24 | 2015-10-07 | シャンハイ インスティテュート オブ オーガニック ケミストリー，チャイニーズ アカデミー オブ サイエンシズ | 新規の遺伝子クラスター |
| BR112012019866A8 (pt) | 2010-02-09 | 2017-12-26 | Biotica Tech Limited | Composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto |
| WO2011098808A1 (en) | 2010-02-09 | 2011-08-18 | Biotica Technology Limited | Sanglifehrin based compounds |
| WO2011098805A1 (en) | 2010-02-09 | 2011-08-18 | Biotica Technology Limited | Sanglifehrin based compounds |
| GB201008123D0 (en) | 2010-05-17 | 2010-06-30 | Biotica Tech Ltd | Novel compounds |
| AR084217A1 (es) | 2010-12-10 | 2013-05-02 | Gilead Sciences Inc | Inhibidores macrociclicos de virus flaviviridae |
| EP2654753B1 (en) | 2010-12-20 | 2018-10-31 | Neurovive Pharmaceutical AB | Sanglifehrin derivatives and methods for their production |
| JO3063B1 (ar) | 2011-03-29 | 2017-03-15 | Neurovive Pharmaceutical Ab | مركب مبتكر وطرق لانتاجه |
| GB201118334D0 (en) | 2011-10-24 | 2011-12-07 | Biotica Tech Ltd | Novel dosage form |
| AR091279A1 (es) | 2012-06-08 | 2015-01-21 | Gilead Sciences Inc | Inhibidores macrociclicos de virus flaviviridae |
| NZ703066A (en) * | 2012-06-08 | 2016-10-28 | Gilead Sciences Inc | Macrocyclic inhibitors of flaviviridae viruses |
| SI2861604T1 (sl) | 2012-06-08 | 2017-05-31 | Gilead Sciences, Inc. | Makrociklični inhibitorji flavivirusov |
| BR112019009903A2 (pt) | 2016-11-18 | 2019-08-13 | Neurovive Pharmaceutical Ab | análogo de sangliferina, combinação, composição farmacêutica, e, método para tratamento de um sujeito sofrendo de câncer ou de malignidade de célula-b |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9318144D0 (en) * | 1993-09-01 | 1993-10-20 | Sandoz Ltd | Organic compounds |
| WO1995015328A1 (en) * | 1993-11-30 | 1995-06-08 | Abbott Laboratories | Macrocyclic immunomodulators with novel cyclohexyl ring replacements |
-
1996
- 1996-07-03 AR ARP960103427A patent/AR006514A1/es unknown
- 1996-07-04 JP JP9504832A patent/JPH11509092A/ja active Pending
- 1996-07-04 IL IL12284496A patent/IL122844A0/xx unknown
- 1996-07-04 HU HU9802320A patent/HUP9802320A3/hu unknown
- 1996-07-04 AU AU65193/96A patent/AU708004B2/en not_active Ceased
- 1996-07-04 CA CA002224715A patent/CA2224715A1/en not_active Abandoned
- 1996-07-04 SK SK4-98A patent/SK498A3/sk unknown
- 1996-07-04 WO PCT/EP1996/002952 patent/WO1997002285A1/en not_active Application Discontinuation
- 1996-07-04 BR BR9609324A patent/BR9609324A/pt not_active Application Discontinuation
- 1996-07-04 EP EP96924886A patent/EP0836616A1/en not_active Withdrawn
- 1996-07-04 CZ CZ974242A patent/CZ424297A3/cs unknown
- 1996-07-04 CO CO96034982A patent/CO4750713A1/es unknown
- 1996-07-04 KR KR1019980700022A patent/KR19990028724A/ko not_active Application Discontinuation
- 1996-07-04 CN CN96196487A patent/CN1193979A/zh active Pending
- 1996-07-04 TR TR1998/00001T patent/TR199800001T1/xx unknown
- 1996-07-04 PL PL96324346A patent/PL324346A1/xx unknown
-
1998
- 1998-01-02 NO NO980016A patent/NO980016L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0836616A1 (en) | 1998-04-22 |
| HUP9802320A3 (en) | 1999-03-29 |
| CN1193979A (zh) | 1998-09-23 |
| KR19990028724A (ko) | 1999-04-15 |
| JPH11509092A (ja) | 1999-08-17 |
| AU6519396A (en) | 1997-02-05 |
| SK498A3 (en) | 1998-07-08 |
| NO980016D0 (no) | 1998-01-02 |
| TR199800001T1 (xx) | 1998-04-21 |
| BR9609324A (pt) | 1999-05-25 |
| AR006514A1 (es) | 1999-09-08 |
| AU708004B2 (en) | 1999-07-29 |
| CZ424297A3 (cs) | 1998-04-15 |
| PL324346A1 (en) | 1998-05-25 |
| MX9800217A (es) | 1998-07-31 |
| WO1997002285A1 (en) | 1997-01-23 |
| HUP9802320A2 (hu) | 1999-02-01 |
| IL122844A0 (en) | 1998-08-16 |
| CO4750713A1 (es) | 1999-03-31 |
| CA2224715A1 (en) | 1997-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO980016L (no) | Makrolider | |
| CA2254408A1 (en) | Hair dye compositions containing 2,3 dialkyl-4-aminophenol and a 2-alkyl-1-naphthol | |
| WO2002003984A3 (en) | Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x | |
| DK0879236T3 (da) | Derivater af camptothecin til anvendelse ved behandling af cancer | |
| TW288011B (cs) | ||
| AU6954887A (en) | Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use | |
| CA2327679A1 (en) | Triphendioxazine dyestuffs for dyeing organic substrates | |
| IE842211L (en) | (Substituted) Phenyl-aliphatic-isoxazoles useful as¹antiviral agents and preparation thereof | |
| DK0518558T3 (da) | 1-methylcarbapenemderivater, deres fremstilling og deres anvendelse som antibiotika | |
| EP1550651A4 (en) | GLYCEROL DERIVATIVE | |
| CA2267945A1 (en) | Anticonvulsant derivatives useful in treating neuropathic pain | |
| WO2001009122A3 (en) | Serotonergic benzofurans | |
| ES2000908A6 (es) | Procedimiento para la fabricacion de nuevos derivados de alquilmercaptofenil-1,3,4-oxadiazol | |
| FR2642755B1 (cs) | ||
| ATE290574T1 (de) | Farbmittelzubereitungen | |
| CA2144344A1 (en) | Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents | |
| BG104302A (en) | Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids | |
| AU3173899A (en) | Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such compound or membrane | |
| ZA9410287B (en) | N-oxides of 4-arylpiperazines and 4-arylpiperidines | |
| CA2011642A1 (en) | Benzoxazine dyes | |
| EA199900684A1 (ru) | Производные иминоазаантрациклинона для лечения амилоидоза | |
| NO983527L (no) | Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler | |
| DK0832085T3 (da) | Phosphinsyrederivater med metallopeptidaseinhiberende aktivitet | |
| CA2123101A1 (en) | Nitroxyalkylamide derivative | |
| CA2236073A1 (en) | Intimal thickening inhibitory agent |